Three generations of epidermal growth factor receptor tyrosine kinase inhibitors developed to revolutionize the therapy of lung cancer
2016 ◽
Vol Volume 10
◽
pp. 3867-3872
◽
2013 ◽
Vol 11
(2)
◽
pp. 161-169
◽